# Deep Learning Model for Lung Cancer Classification
This is a depp learning model for lung cancer images classification trained with a dataset retrieved from Kaggle and originally published in arXiv, a free distribution service and open-source achive. 

## Dataset
The original dataset was published by arXiv.org and consists of 25,000 images with 5 different classes of 5,000 images each and two main subclasses: colon and lung images. 

For this project, only the **lung images** where used. The dataset for lung images contains the following classes with 5,000 images each:
| Class                   | Type            | Number of Images |
| ----------------------- | --------------- | ---------------- |
| Squamous Cell Carcinoma | Malignant Tumor | 5,000            |
| Adenocarcinomas         | Malignant Tumor | 5,000            |
| Bening lung tissues     | Not Cancer      | 5,000            |


<br>

All images are 768 x 769 pixels in size and in jpeg format.

<br>

You can download the dataset from:
- [Kaggle dataset](https://www.kaggle.com/datasets/rm1000/lung-cancer-histopathological-images/data) (used in this project).
- [arXiv.org publication](https://arxiv.org/abs/1912.12142v1)
- [GitHub repository](https://github.com/tampapath/lung_colon_image_set)

## Project File Structure
<pre><code>
ml-lung-cancer-classification/
â”œâ”€â”€ README.md
â”œâ”€â”€ requirements.txt
â”œâ”€â”€ lung_cancer.ipynb
â”œâ”€â”€ dataset/
â”‚   â””â”€â”€ input/
â”‚       â””â”€â”€ adenonacarcinoma/
â”‚       â””â”€â”€ benign/
â”‚       â””â”€â”€ squamous_cell_carcinoma/
â””â”€â”€ .gitignore
</code></pre>

## Data preprocessing and data splitting

### Data loading
The data is loaded from the `dataset_path` variable, which is set to the `/dataset/input` directory.

After that, all images are proccesed and loaded into a `pandas` `DataFrame` for better data manipulation.

### Data splitting
The data is then splitted into three groups as follows:
| Dataset Split | Percentage | Number of Images |
| ------------- | ---------- | ---------------- |
| Training      | 60%        | 9,000            |
| Validation    | 20%        | 3,000            |
| Testing       | 20%        | 3,000            |


### Image Data Generator

For smoother training and improved model performance, the `ImageDataGenerator` class from the `tensorflow.keras.preprocessing.image` module was utilized. This class enables efficient preprocessing and real-time data augmentation, which helps the model generalize better to unseen data.

The following data generators were created:

- **Train Data Generator**: Used to feed augmented images to the model during training, helping reduce overfitting.
- **Validation Data Generator**: Used to evaluate the model's performance on unseen (non-augmented) data during training.
- **Test Data Generator**: Used to assess the final performance of the trained model on completely unseen data after training is complete.

#### Benefits of Using an Image Data Generator

Using `ImageDataGenerator` offers several advantages:

- **Real-time Data Augmentation**: Applies random transformations (e.g., rotation, zoom, flipping) on the fly, increasing dataset diversity without increasing memory usage.
- **Memory Efficiency**: Loads and processes data in batches, which is essential when working with large datasets.
- **Improved Generalization**: By exposing the model to varied data through augmentation, it becomes more robust and less likely to overfit.
- **Built-in Preprocessing**: Easily apply rescaling, normalization, and other preprocessing steps directly within the generator.
- **Seamless Integration with Keras**: Easily plugs into the `.fit()` or `.fit_generator()` methods for model training.

#### Applied Data Augmentation Techniques
To enhance the training data and improve the model's ability to generalize, the following augmentation techniques were applied:

- `rescale=1.0 / 255.0`: Normalizes pixel values to the range `[0, 1]`, which helps in faster and more stable training.
- `rotation_range=20`: Randomly rotates images up to `20 degrees`, helping the model become invariant to orientation.
- `width_shift_range=0.2`: Randomly shifts images horizontally by up to `20%` of the width.
- `height_shift_range=0.2`: Randomly shifts images vertically by up to `20%` of the height.
- `zoom_range=0.2`: Randomly zooms in on images by up to `20%`, allowing the model to learn from different scales.
- `horizontal_flip=True`: Randomly flips images horizontally, useful for symmetry-invariant features.

These transformations are applied only during training to simulate real-world variability. The validation and test sets are rescaled but left unaltered to evaluate model performance on consistent data.

## Model Architecture

### First Model

The initial model was a straightforward **Convolutional Neural Network (CNN)** implemented using Keras' `Sequential` API. This architecture was designed to serve as a baseline for image classification of lung CT scans into benign and malignant categories.

The model architecture consists of the following layers:

- `Conv2D`: Applies 32 filters of size 3x3 with ReLU activation to detect low-level features such as edges and textures.
- `MaxPooling2D`: Downsamples feature maps to reduce spatial dimensions and computation, while retaining important information.
- `Conv2D`: A second convolutional layer with 64 filters to capture more complex patterns and structures.
- `MaxPooling2D`: Further reduces the spatial size and helps in generalization.
- `Flatten`: Converts the 2D feature maps into a 1D feature vector for the dense layers.
- `Dense`: A fully connected layer with 128 neurons and ReLU activation, serving as a high-level feature aggregator.
- `Dense`: Output layer with softmax activation to generate probability scores for each class (benign or malignant).

This model was compiled using the **categorical cross-entropy loss** function and optimized with **RMSprop** (learning rate = `2e-5`). The evaluation metrics included accuracy, precision, and recall.

### Upgraded Model

The upgraded model is an **Enhanced Convolutional Neural Network (CNN)** architecture inspired by the design presented in the research article *â€œDeep learning-based approach to diagnose lung cancer using CT-scan images.â€* This version significantly expands on the baseline architecture by introducing deeper feature extraction, more capacity, and overfitting prevention mechanisms. It is intended to improve classification accuracy across four lung tissue types: **adenocarcinoma**, **large cell carcinoma**, **squamous cell carcinoma**, and **normal**.

The model architecture consists of the following layers:

- **`Conv2D`**: The first layer applies **64 filters** of size `3x3` with ReLU activation. This layer captures fine-grained features from the input CT scan images.
- **`MaxPooling2D`**: Reduces spatial dimensions (downsampling), helping the network generalize by retaining dominant features.
- **`Conv2D`**: Applies **32 filters** of size `3x3` with ReLU activation to learn more abstract representations.
- **`MaxPooling2D`**: Further downsamples the feature maps, aiding in spatial hierarchy learning and reducing overfitting risk.
- **`Conv2D`**: Another layer with **32 filters** of size `3x3` and ReLU activation. This deepens the feature extraction pipeline.
- **`Dropout`**: A dropout layer with a rate of **0.4**, randomly disabling 40% of neurons during training to reduce overfitting.
- **`Flatten`**: Converts the multi-dimensional feature maps into a 1D feature vector to be fed into dense layers.
- **`Dense`**: A fully connected layer with **256 units** and ReLU activation for high-level reasoning across learned features.
- **`Dropout`**: A second dropout layer with a rate of **0.4**, again to prevent overfitting during training.
- **`Dense`**: A secondary dense layer with **128 units** and ReLU activation to refine the feature space before classification.
- **`Dense`**: The final layer includes **4 output units** with **softmax activation**, returning a probability distribution over the four target classes.

The model is compiled with the **categorical cross-entropy** loss function and the **Adam optimizer** with a learning rate of `1e-3`. It evaluates performance using **accuracy**, **precision**, and **recall**.

This enhanced architecture demonstrated **superior performance** in the referenced research, achieving **100% testing accuracy**, and is designed to improve generalization and robustness, especially in multi-class medical image classification tasks.

### Final Model

## Results

### First Model Performance

After training for **20 epochs**, the first model demonstrated solid performance on both the validation and test datasets. Below are the key metrics:

- **Training Accuracy**: 90.74%
- **Validation Accuracy**: 91.67%
- **Test Accuracy**: 92.50%

These results indicate that the model was able to generalize well without significant overfitting. The training and validation losses are closely aligned, and the test accuracy confirms the model's ability to correctly classify unseen CT scan images with high reliability.

### Evaluation Metrics

To further assess the performance of the model, we computed detailed classification metrics using the test dataset. The following confusion matrix and classification report provide insights into how well the model performed for each class:

#### Confusion Matrix

The confusion matrix below shows the number of correct and incorrect predictions made by the model for each class:

![Confusion Matrix First Model](/assets/model_1.png)


#### Classification Report

| Class                  | Precision | Recall | F1-Score | Support |
| ---------------------- | --------- | ------ | -------- | ------- |
| **Squamous Cell (0)**  | 0.86      | 0.92   | 0.89     | 1000    |
| **Adenocarcinoma (1)** | 0.99      | 0.96   | 0.97     | 1000    |
| **Benign (2)**         | 0.92      | 0.89   | 0.91     | 1000    |
| **Accuracy**           |           |        | **0.90** | 3000    |

These metrics indicate that:

- The model performs **exceptionally well** in identifying **Adenocarcinoma** cases, with a **precision of 0.99** and **recall of 0.96**, suggesting high reliability in detecting this cancer type.
- Performance on **Benign** samples is also strong (**F1-score: 0.91**), indicating effective discrimination from malignant tissues.
- **Squamous Cell Carcinoma** detection shows a **recall of 0.92**, but the **precision drops to 0.86**, largely due to a **notable number of false negatives** â€” **106 samples** misclassified as benign, as seen in the confusion matrix.

> âš ï¸ These false negatives are especially problematic, as they represent **malignant tumors wrongly identified as non-cancerous**, which could lead to **missed or delayed treatments** in a real-world clinical scenario.

- The overall **accuracy of 90%** and **macro average F1-score of 0.92** reflect robust generalization and balanced performance across the classes.

### ðŸ” Considerations for Future Improvements

This analysis highlights the need for further refinement, especially in reducing false negatives for **Squamous Cell Carcinoma**. Future efforts could explore:

- **Data augmentation** focused on squamous cell features to improve representation during training.
- **Class rebalancing or weighted loss functions** to penalize misclassification of malignant cases more heavily.
- **Ensemble methods or attention mechanisms** to enhance the modelâ€™s focus on subtle visual patterns differentiating cancer types from benign tissue.

> **Note**: The "Support" column represents the number of true instances for each class in the test set. This helps contextualize the performance metrics and interpret the impact of misclassifications.


### Upgraded Model Performance
After training for **20 epochs**, the first model demonstrated solid performance on both the validation and test datasets. Below are the key metrics:

- **Training Accuracy**: 91.71%
- **Validation Accuracy**: 94.83%
- **Test Accuracy**: 95.62%

These results indicate that the model was able to generalize well without significant overfitting. The training and validation losses are closely aligned, and the test accuracy confirms the model's ability to correctly classify unseen CT scan images with high reliability.

### Evaluation Metrics

To further assess the performance of the model, we computed detailed classification metrics using the test dataset. The following confusion matrix and classification report provide insights into how well the model performed for each class:

#### Confusion Matrix

The confusion matrix below shows the number of correct and incorrect predictions made by the model for each class:

![Confusion Matrix First Model](/assets/model_2.png)


#### Classification Report

| Class                  | Precision | Recall | F1-Score | Support |
| ---------------------- | --------- | ------ | -------- | ------- |
| **Squamous Cell (0)**  | 0.92      | 0.94   | 0.93     | 1000    |
| **Adenocarcinoma (1)** | 1.00      | 1.00   | 1.00     | 1000    |
| **Benign (2)**         | 0.95      | 0.92   | 0.93     | 1000    |
| **Accuracy**           |           |        | **0.95** | 3000    |


These metrics indicate that:

- The model now performs **exceptionally well** on **Adenocarcinoma**, achieving **perfect precision and recall (1.00)**. This means every Adenocarcinoma case was correctly identified without a single false positive or false negative â€” a **significant improvement** over the first model.

- **Benign** cases show improved precision (**0.95**) and a recall of **0.92**, indicating fewer benign samples are being misclassified as malignant compared to the first model. Notably, the number of **false positives from benign to squamous cell carcinoma** dropped from 106 to 81, improving diagnostic safety.

- **Squamous Cell Carcinoma** detection has also improved, with both **precision (0.92)** and **recall (0.94)** increasing. The confusion matrix shows only **4 cases misclassified as adenocarcinoma**, and **53 as benign** â€” a reduction from 78 benign misclassifications in the first model. This directly addresses one of the biggest weaknesses in the original model.

> âœ… These improvements indicate the upgraded model is **more reliable in distinguishing malignant from benign tissue**, especially for Squamous Cell Carcinoma, where false negatives were previously a concern.

- The overall **accuracy increased from 90% to 95%**, and the **macro average F1-score rose to 0.95**, reflecting a **more balanced and robust performance across all classes**.



### Final Model Performance

## Bibliography
For the development of this project, the following article served as a key reference and foundation:

- Deep learning-based approach to diagnose lung cancer using CT-scan image
Yasser Khan, M.M. Kamruzzaman, et al.
https://doi.org/10.1016/j.ibmed.2024.100188

This state-of-the-art article presents a cutting-edge deep learning approach for diagnosing lung cancer using CT scan images. It provided critical insights into model architecture, image preprocessing, and evaluation strategies. The methodology outlined in this research significantly influenced the dataset preparation, data augmentation techniques, and model design choices in this project.
